Tic disorder

May Is Maternal Mental Health Month; Postpartum Support International Urges Friends, Family to Check on New and Expectant Moms, Discuss Mental Health

Retrieved on: 
Wednesday, May 1, 2024
Psychosis, Tears, Shame, Hope, Risk, Woman, Tic disorder, Post-traumatic stress disorder, Bipolar disorder, Research, Parent, Depression, Directory, Cooking, Culture, Mental health, PSI, Mother, Availability, PMH, Anxiety, Nursing

PORTLAND, Ore., May 1, 2024 /PRNewswire/ -- May brings National Maternal Mental Health Month, World Maternal Mental Health Day (May 1), and Mother's Day (May 12), making it an ideal time to talk about perinatal mental health (PMH) and to educate mothers and the people in their lives about postpartum depression and other PMH disorders. Nonprofit Postpartum Support International (PSI) is working to improve PMH disorder awareness and access to free support and care while reducing stigma around perinatal mental health disorders.  

Key Points: 
  • Nonprofit Postpartum Support International (PSI) is working to improve PMH disorder awareness and access to free support and care while reducing stigma around perinatal mental health disorders.
  • Each May, PSI puts extra emphasis on educating the public during National Maternal Mental Health Month.
  • May is also when Americans celebrate mothers and motherhood, which is anything but joyful for those suffering from a PMH disorder.
  • Laundry, cooking or ordering takeout, and watching the baby so she can have time alone are all ways to provide support.

Relief Mental Health Sheds Light on Innovative Treatments During Mental Health Awareness Month

Retrieved on: 
Wednesday, May 1, 2024
Mental Health, Alternative Medicine, Other Health, Health, Pharmaceutical, FDA, Brain, Hope, Tic disorder, Mental Health Awareness Month, DSM-IV codes, OCD, PTSD, Field line, MD, Depression, Grammatical mood, Ketamine, Mental health, Transcranial magnetic stimulation, Anxiety, TMS, Pharmaceutical industry

As Mental Health Awareness Month kicks off today, Relief Mental Health aims to spotlight innovative therapies that offer hope to individuals struggling with mental health diagnoses.

Key Points: 
  • As Mental Health Awareness Month kicks off today, Relief Mental Health aims to spotlight innovative therapies that offer hope to individuals struggling with mental health diagnoses.
  • "TMS, Spravato, and IV ketamine represent a new frontier in mental health treatment, offering relief to those who have struggled with traditional therapies,” said Teresa Poprawski, MD , a neuropsychiatrist and chief medical officer at Relief Mental Health.
  • In honor of Mental Health Month and to help educate the public on the benefits of TMS specifically, Relief Mental Health is hosting an Instagram Live event on Friday, May 17, at 10 a.m. central time.
  • For more information about Relief Mental Health or to schedule a consultation for any of its services, individuals can call 855.205.4764, email [email protected] or visit reliefmh.com .

United States Gluten-Free Food Products Market Insights 2024: A $4.25 Billion Industry by 2029, Driven by Rising Incidence of Intolerance & Increasing Availability of Diversified Options - ResearchAndMarkets.com

Retrieved on: 
Friday, April 26, 2024
Food, Beverage, Retail, Online, Snack, Irritable bowel syndrome, Flour, Hain Celestial Group, Flowers Foods, Prevalence, Health, Kraft Heinz, Male, Coeliac disease, Life, Mondelez International, Arthritis, Incidence, Supermarket, Perception, Tic disorder, Bread, General Mills, Growth

The U.S. gluten-free food products market is expected to reach a value of 4.25 billion by 2029 from $2.62 billion in 2023, growing at a CAGR of 8.36%

Key Points: 
  • The U.S. gluten-free food products market is expected to reach a value of 4.25 billion by 2029 from $2.62 billion in 2023, growing at a CAGR of 8.36%
    The U.S. gluten-free food products market report contains exclusive data on 28 vendors.
  • The US gluten-free food products market is highly competitive, with established players and emerging brands competing for market share.
  • The rising incidence of celiac disease and gluten intolerance is a major driver in the U.S. gluten-free food products market.
  • The increasing availability of diversified gluten-free food options is a key driver in the U.S. market, contributing to its ongoing growth.

Postpartum Support International Launches First Mobile App, Giving Quicker Access to Perinatal Mental Health Support, Free Resources

Retrieved on: 
Monday, April 15, 2024
Volunteering, Psychosis, Google Play, Tic disorder, Post-traumatic stress disorder, Pregnancy, Woman, Bipolar disorder, Parent, Depression, Culture, Mental health, PSI, PMH, Anxiety, Connect, App Store (iOS/iPadOS), Nursing

PORTLAND, Ore., April 15, 2024 /PRNewswire/ -- Postpartum Support International today officially released its new mobile application, Connect by PSI. The app was developed as part of PSI's commitment to give all families the best start possible and to make support and free resources, related to perinatal mental health disorders (PMHD), easily accessible. The app aims to address the needs of the full spectrum of the perinatal mental health community: new parents, people experiencing a loss, healthcare professionals, and more.

Key Points: 
  • PORTLAND, Ore., April 15, 2024 /PRNewswire/ -- Postpartum Support International today officially released its new mobile application, Connect by PSI.
  • The app was developed as part of PSI's commitment to give all families the best start possible and to make support and free resources, related to perinatal mental health disorders (PMHD), easily accessible.
  • Educational resources: Access articles and other materials covering various topics related to perinatal mental health, including self-care tips, coping strategies, and treatment options.
  • "This app embodies our commitment to providing accessible, stigma-free support for individuals navigating the mental health challenges surrounding pregnancy, postpartum, and/or loss.

Rice Biotech Launch Pad startup Motif Neurotech announces peer-reviewed publication on wireless cortical stimulator for precise neuromodulation

Retrieved on: 
Friday, April 12, 2024
Leg, Brain, Inflammation, College of Engineering (KNUST), Post-traumatic stress disorder, Safety, Neuromodulation, Science Advances, Animal, Field line, Hand, Pathology, Depression, Tic disorder, Motor cortex, Mental health, Patient, Spinal cord, Miniature, DOT, DSM-IV codes, Transcranial magnetic stimulation, Digital, Manuscript, Rice University, TMS

HOUSTON, April 12, 2024 /PRNewswire/ -- Rice University today announced that Jacob Robinson, a professor of electrical and computer engineering and of bioengineering and founder and chief executive officer of Motif Neurotech, a neurotechnology company developing minimally invasive bioelectronics for mental health formed through the Rice Biotech Launch Pad, published a peer-reviewed study in Science Advances detailing a novel and wireless device - an epidural cortical stimulator known as the Digitally programmable Over-brain Therapeutic (DOT), that is capable of receiving enough energy to stimulate human and large-animal brain activity and can deliver bursts of electrical stimulation to the brain through the dura, the tough membrane that covers the brain and the spinal cord. The manuscript entitled "Miniature battery-free epidural cortical stimulators" can be viewed on the Science Advances website.

Key Points: 
  • The manuscript entitled " Miniature battery-free epidural cortical stimulators " can be viewed on the Science Advances website.
  • "However, current neuromodulation devices are either bulky, invasive, or limited in their stimulation capabilities.
  • It overcomes challenges by using a battery-free and wireless approach  to create an implant that can deliver precise and programmable stimulation to the brain, without brain surgery."
  • The study details how the DOT stimulator works by using magnetoelectric antennas that can convert magnetic fields into electric fields and vice versa.

Spravato® Therapy at Hudson Mind Ushers in New Era of Accessible Care for Treatment-Resistant Depression

Retrieved on: 
Tuesday, April 16, 2024
Esketamine, FDA, Brain, Post-traumatic stress disorder, Thought, Insurance, Transcranial magnetic stimulation, Depression, Tic disorder, Patient, Mental health, Ketamine, Anxiety, Nursing

NEW YORK, April 11, 2024 /PRNewswire/ -- Hudson Mind, an interventional mental health clinic in New York City, announces the addition of Spravato® (https://mind.hudson.health/treatments/spravato/). The integration of Spravato opens the door to more accessible treatment options for patients with major depression.

Key Points: 
  • NEW YORK, April 11, 2024 /PRNewswire/ -- Hudson Mind, an interventional mental health clinic in New York City, announces the addition of Spravato® ( https://mind.hudson.health/treatments/spravato/ ).
  • The integration of Spravato opens the door to more accessible treatment options for patients with major depression.
  • Hudson Mind psychiatrist Dr. Marcel Green is eager to introduce more patients to the burgeoning interventional mental health landscape, starting with Spravato.
  • "At Hudson Mind, we emphasize that ketamine represents a revolutionary advancement in mental health care.

Wellpoint Increases Access to Mental Healthcare for Children and Young Adults with Addition of InStride Health to Network

Retrieved on: 
Monday, March 11, 2024
Practice Management, Insurance, Managed Care, Health, Mental Health, Professional Services, Health Insurance, Other Health, Depression, Family therapy, Patient, Mental health, Social isolation, Anxiety, OCD, Disability, Mass, Life, Tic disorder, UniCare, Commonwealth, Nursing

As part of Wellpoint’s (formerly UniCare) ongoing work to increase access to mental healthcare for its members, Wellpoint recently welcomed InStride Health, a pediatric anxiety and obsessive-compulsive disorder (OCD) treatment provider, to its expansive provider network.

Key Points: 
  • As part of Wellpoint’s (formerly UniCare) ongoing work to increase access to mental healthcare for its members, Wellpoint recently welcomed InStride Health, a pediatric anxiety and obsessive-compulsive disorder (OCD) treatment provider, to its expansive provider network.
  • Wellpoint administers health benefits for more than 200,000 state and municipal employees, retirees, and their families insured by the Commonwealth of Massachusetts Group Insurance Commission.
  • “At Wellpoint, we’re committed to supporting our members’ whole health – their physical, mental, emotional, and social well-being.
  • For more information about InStride Health, visit instride.health .

STATE SENATORS SUPPORT THE OPENING OF YOUR SIX RECOVERY, A VETERANS ADDICTION TREATMENT PROGRAM AT SWIFT RIVER ADDICTION CAMPUSES IN CUMMINGTON, MASS.

Retrieved on: 
Thursday, March 21, 2024
Trust, Statistics, Face, Veteran, Environment, Tic disorder

CUMMINGTON, Mass., March 21, 2024 /PRNewswire/ -- Your Six Recovery , a specialized addiction treatment program for U.S. veterans and a part of Swift River, celebrated the opening of its new facility in Cummington, Massachusetts, with a ribbon-cutting ceremony.

Key Points: 
  • CUMMINGTON, Mass., March 21, 2024 /PRNewswire/ -- Your Six Recovery , a specialized addiction treatment program for U.S. veterans and a part of Swift River, celebrated the opening of its new facility in Cummington, Massachusetts, with a ribbon-cutting ceremony.
  • Paul Mark and John Velis, who expressed their support for the program's mission to provide comprehensive care for veterans struggling with substance use disorders and mental health challenges.
  • He added, "Programs like Your Six Recovery work to ensure those who have served, our defenders, are cared for."
  • The program offers evidence-based services to help veterans navigate the challenges they face in recovery, fostering an environment of camaraderie and trust.

NourishedRx Enters into Strategic Partnership with Alliance Health to Support Members Enrolled in Transitions to Community Living (TCL) Program

Retrieved on: 
Tuesday, March 19, 2024
Well, Depression, Health, Case management, Health equity, Partnership, Social support, Community health, Education, SVP, Mental health, Well-being, TCL, Food, Community integration, Brain damage, Housing, Loneliness, Tic disorder, Nursing

STAMFORD, Conn., March 19, 2024 /PRNewswire/ -- Alliance Health, a North Carolina-based behavioral health care services managed care company, announced today that it has entered into a strategic partnership with NourishedRx, a digital health and nutrition company based in Stamford, Connecticut, to support eligible members enrolled in North Carolina's Transitions to Community Living (TCL) program. The new partnership will enable Alliance Health to better serve TCL program members transitioning from institutional care settings into community living by providing them with nutritious home-delivered food and associated nutritional support services.

Key Points: 
  • STAMFORD, Conn., March 19, 2024 /PRNewswire/ -- Alliance Health, a North Carolina-based behavioral health care services managed care company, announced today that it has entered into a strategic partnership with NourishedRx, a digital health and nutrition company based in Stamford, Connecticut, to support eligible members enrolled in North Carolina's Transitions to Community Living (TCL) program.
  • The new partnership will enable Alliance Health to better serve TCL program members transitioning from institutional care settings into community living by providing them with nutritious home-delivered food and associated nutritional support services.
  • The partnership's goals are to positively impact tenancy and independent living, improve participants' nutrition security, support health equity, and improve self-reported health outcomes.
  • "We're excited to engage with NourishedRx in our effort to improve the health and lives of North Carolinians in need of these services."

BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights

Retrieved on: 
Wednesday, March 6, 2024
TMS, Parkinson's disease, Medicine, Mental health, Human, Traction, Growth, Stroke, Adjustment, Safety, DSM-IV codes, Tic disorder, Mixed anxiety–depressive disorder, Brainsway, Journal, Rehabilitation, Science, OCD, Transcranial magnetic stimulation

BURLINGTON, Mass. and JERUSALEM, March 06, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported fourth quarter and full-year 2023 financial results and provided an operational update.

Key Points: 
  • and JERUSALEM, March 06, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported fourth quarter and full-year 2023 financial results and provided an operational update.
  • Gross margin for the fourth quarter of 2023 was 75%, an increase from 71% in the fourth quarter of 2022, and an increase from 74% in the third quarter of 2023.
  • Net income for the fourth quarter of 2023 was $0.1 million, compared to a net loss of $3.9 million for the fourth quarter of 2022, and a loss of $0.2 million for the third quarter of 2023.
  • Adjusted EBITDA1 for the fourth quarter of 2023 was approximately $0.8 million, compared to a loss of $3.6 million for the fourth quarter of 2022, and positive Adjusted EBITDA1 of $0.3 million in the third quarter of 2023.